dc.contributor.author | Bruder, O | en_US |
dc.contributor.author | Wagner, A | en_US |
dc.contributor.author | Lombardi, M | en_US |
dc.contributor.author | Schwitter, J | en_US |
dc.contributor.author | van Rossum, A | en_US |
dc.contributor.author | Pilz, G | en_US |
dc.contributor.author | Nothnagel, D | en_US |
dc.contributor.author | Steen, H | en_US |
dc.contributor.author | Petersen, S | en_US |
dc.contributor.author | Nagel, E | en_US |
dc.contributor.author | Prasad, S | en_US |
dc.contributor.author | Schumm, J | en_US |
dc.contributor.author | Greulich, S | en_US |
dc.contributor.author | Cagnolo, A | en_US |
dc.contributor.author | Monney, P | en_US |
dc.contributor.author | Deluigi, CC | en_US |
dc.contributor.author | Dill, T | en_US |
dc.contributor.author | Frank, H | en_US |
dc.contributor.author | Sabin, G | en_US |
dc.contributor.author | Schneider, S | en_US |
dc.contributor.author | Mahrholdt, H | en_US |
dc.date.accessioned | 2015-07-28T14:31:04Z | |
dc.date.available | 2012-12-20 | en_US |
dc.date.issued | 2013-01-18 | en_US |
dc.identifier.issn | 1097-6647 | en_US |
dc.identifier.other | ARTN 9 | en_US |
dc.identifier.other | ARTN 9 | en_US |
dc.identifier.other | ARTN 9 | en_US |
dc.identifier.other | ARTN 9 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/8040 | |
dc.description | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited | en_US |
dc.description.sponsorship | The EuroCMR Registry is supported by unrestricted educational grants from the following companies (in alphabetic order): ●Medtronic Inc., Minneapolis MN, USA. ●Novartis International AG, Basel, Switzerland. ●Siemens Health Care, Erlangen, Germany. Importantly, industry sponsoring was exclusively used for registry data management and analysis. All CMR scans reported in this registry were clinically indicated according to the actual appropriateness criteria [3], and thus completely funded by the regular health care providers. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE | en_US |
dc.subject | Cardiovascular magnetic resonance | en_US |
dc.subject | Registry | en_US |
dc.subject | Quality | en_US |
dc.subject | Safety | en_US |
dc.subject | Therapeutic implications | en_US |
dc.subject | Impact | en_US |
dc.subject | Patient management | en_US |
dc.title | European cardiovascular magnetic resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1186/1532-429X-15-9 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315380000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 15 | en_US |
qmul.funder | Biomedical Research Unit at Barts (CVBRU)::NIHR | en_US |
qmul.funder | Biomedical Research Unit at Barts (CVBRU)::NIHR | en_US |